Trade

Anthem BioSciences share price

Balanced risk
  • 34%Low risk
  • 34%Moderate risk
  • 34%Balanced risk
  • 34%High risk
  • 34%Extreme risk
  • 705.05(1.15%)
    November 10, 2025 15:58:56 PM IST
    • NSE
    • BSE
  • Vol : 1.79M (NSE + BSE)
    Last 20 day avg : 523.44 K

Anthem BioSciences is trading 1.15% upper at Rs 705.05 as compared to its last closing price. Anthem BioSciences has been trading in the price range of 708.00 & 668.00. The Mutual Fund holding in Anthem BioSciences was at 6.68% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Anthem BioSciences was at 1.66% in 30 Sep 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Nov 11, 2025, 02:44 AM UTC

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.05
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    21.39
    Indicates overvaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
Price range
Day Range
Lowest
668.00
Highest
708.00
52 week range
Lowest
685.55
Highest
873.25
Anthem BioSciences Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe debt to equity of the company is lower than the industry median
Anthem BioSciences Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 721.17
  • R2
  • 739.68
  • R3
  • 766.27
Pivot694.58
  • S1
  • 676.07
  • S2
  • 649.48
  • S3
  • 630.97
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Anthem BioSciences Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Anthem BioSciences is currently unavailable
    Please check back later.
    Shareholding Insights
    No Data
    Shareholding insights for Anthem BioSciences are currently unavailable
    Please check back later.
    Anthem BioSciences Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-11-08Quarterly Results
    2025-08-13Quarterly Results
    About the company Anthem BioSciences
    • Industry
    • ISININE0CZ201020
    • BSE Code544449
    • NSE CodeANTHEM
    • Management Info
    No Data
    Management info for Anthem BioSciences is currently unavailable
    Please check back later.
    Anthem BioSciences Share Price FAQs

    Anthem BioSciences is trading at 705.05 as on Mon Nov 10 2025 10:28:56. This is 1.15% upper as compared to its previous closing price of 697.00.

    The market capitalization of Anthem BioSciences is 39596.32 Cr as on Mon Nov 10 2025 10:28:56.

    The 52 wk high for Anthem BioSciences is 873.25 whereas the 52 wk low is 685.55

    Anthem BioSciences can be analyzed on the following key metrics -

    • TTM P/E:
    • Sector P/E: 36.91
    • Dividend Yield: 0.00%
    • D/E ratio: -

    Anthem BioSciences reported a net profit of 451.26 Cr in 2025.

    The Mutual Fund Shareholding was 6.68% at the end of 30 Sep 2025.